A recent study conducted by investigators at the LVR University Hospital in Germany together with Algea Care, a leading telehealth service in Europe focusing on marijuana, sheds light into the efficacy of medical marijuana for treating chronic depression. The results of the groundbreaking study was published in peer-reviewed journals, including the Pharmacopsychiatry of the Association for Neuropsychopharmacology and Pharmacopsychiatry.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…